{"id":"W2128418183","doi":"10.1016/j.crohns.2008.05.011","title":"Management of loss of response to anti-TNF drugs: Change the dose or change the drug?","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tachyphylaxis; Medicine; Monoclonal antibody; Drug; Certolizumab pegol; Adalimumab; Immunogenicity; Infliximab; Pharmacology; Ulcerative colitis; Pharmacokinetics; Immunology; Tumor necrosis factor alpha; Monoclonal; Refractory (planetary science); Antibody; Disease; Internal medicine; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001434308,0.0007451923,0.001356776,0.0006456142,0.0006046416,0.001495005,0.001102383,0.004416982,0.003066573],"category_scores_gemma":[0.003153249,0.0001603711,0.0006299441,0.0003606153,0.00153002,0.001970804,0.0007129473,0.005466215,0.001926526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008897331,"about_ca_system_score_gemma":0.001291769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007400629,"about_ca_topic_score_gemma":0.001649917,"domain_scores_codex":[0.9990391,0.0002913221,0.0001350408,0.0001025496,0.0003133321,0.0001187521],"domain_scores_gemma":[0.9985959,0.0004345556,0.000291274,0.00004827346,0.0003097767,0.0003202657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001003205,0.001003138,0.003930484,0.002791403,0.0001605138,0.004111992,0.0003086893,0.0005583735,0.006403878,0.009023947,0.08284328,0.8878611],"study_design_scores_gemma":[0.001033263,0.004096315,0.01047707,0.00802547,0.0005271601,0.02667009,0.002190783,0.002527715,0.007952433,0.02771773,0.9084945,0.0002875373],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01849946,0.5597634,0.02524693,0.3637615,0.0153927,0.0003546596,0.0001079184,0.0004425519,0.01643081],"genre_scores_gemma":[0.1667251,0.4924405,0.05145049,0.2299603,0.03803346,0.0005979903,0.0002241053,0.0001541617,0.02041386],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004416982,"threshold_uncertainty_score":0.01025867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798083743299159,"score_gpt":0.2615269298410383,"score_spread":0.2435460924080467,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}